Drugs / Ethinylestradiol/Levonorgestrel
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03193307 | Jun → Dec 2017 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ethinylestradiol/Levonorgestrel | “Following Oral Administration of Ethinylestradiol/Levonorgestrel (Microgynon®) and BI 409306 in Healthy Korean Premenopausal Female Subjects (an Open-label, Two-period,...” NCT03193307 ↗ |
| Known as | Microgynon | “Following Oral Administration of Ethinylestradiol/Levonorgestrel (Microgynon®) and BI 409306 in Healthy Korean Premenopausal Female Subjects (an Open-label, Two-period,...” NCT03193307 ↗ |
| Route | Oral | “Following Oral Administration of Ethinylestradiol/Levonorgestrel (Microgynon®) and BI 409306” NCT03193307 ↗ |